Division of Cardiology

Medicine & Life Sciences

1. Acid Sensing Ion Channels 11%
2. Allografts 18%
3. Amiodarone 17%
4. Angiography 11%
5. Anti-Arrhythmia Agents 16%
6. Arterial Pressure 37%
7. Atrial Fibrillation 74%
8. Atrial Flutter 14%
9. Baroreflex 20%
10. Blood Pressure 41%
11. Blood Vessels 27%
12. Bundle-Branch Block 15%
13. Capsaicin 10%
14. Cardiac Arrhythmias 31%
15. Cardiac Catheterization 21%
16. Cardiac Resynchronization Therapy 83%
17. Cardiology 20%
18. Cardiomyopathies 25%
19. Cardiovascular Diseases 11%
20. Catheter Ablation 16%
21. Catheterization 14%
22. Catheters 17%
23. Cats 30%
24. Clinical Trials 11%
25. Confidence Intervals 19%
26. Coronary Artery Disease 15%
27. Coronary Vessels 15%
28. Defibrillators 17%
29. Dogs 22%
30. Doppler Echocardiography 11%
31. Dronedarone 11%
32. Echocardiography 23%
33. Electrocardiography 12%
34. Equipment and Supplies 28%
35. Everolimus 10%
36. Exercise 32%
37. Extremities 16%
38. Femoral Artery 30%
39. Forearm 30%
40. Heart 42%
41. Heart Diseases 19%
42. Heart Failure 100%
43. Heart Rate 29%
44. Heart Transplantation 35%
45. Heart-Assist Devices 29%
46. Heat-Shock Response 10%
47. Hemodynamics 20%
48. Hemorrhage 13%
49. Hindlimb 28%
50. Hospitalization 16%
51. Hypertension 14%
52. Hypoxia 11%
53. Implantable Defibrillators 18%
54. Incidence 12%
55. Ischemia 14%
56. Kidney 15%
57. Lactic Acid 11%
58. Left Ventricular Function 18%
59. Leg 11%
60. Lower Body Negative Pressure 16%
61. Lower Extremity 10%
62. Lung 12%
63. Meta-Analysis 13%
64. Mortality 29%
65. Muscle Contraction 34%
66. Muscles 91%
67. Myocardial Infarction 21%
68. Neurons 13%
69. Nitric Oxide 12%
70. Norepinephrine 12%
71. Odds Ratio 12%
72. Percutaneous Coronary Intervention 29%
73. Peripheral Arterial Disease 31%
74. Placebos 11%
75. Population 10%
76. Pressoreceptors 11%
77. Pressure 24%
78. Pulmonary Hypertension 10%
79. Radial Artery 16%
80. Randomized Controlled Trials 11%
81. Reflex 91%
82. Registries 22%
83. Safety 17%
84. Skeletal Muscle 33%
85. Skin 14%
86. Stroke 21%
87. Stroke Volume 24%
88. Survival 15%
89. Tachycardia 24%
90. Therapeutics 28%
91. Thigh 15%
92. Transplant Recipients 13%
93. Transplantation 10%
94. Transplants 24%
95. Vascular Resistance 12%
96. Vasoconstriction 26%
97. Vasoconstrictor Agents 10%
98. Vasodilation 15%
99. Vasodilator Agents 10%
100. Ventricular Tachycardia 21%